Prof. Dr. Sabine Weber

Resident gastroenterology and hepatology, LMU university hospital, Munich, Germany

Field of Research: Acute liver injury, acute liver failure, drug-induced liver injury, chronic liver diseases, autoimmune and cholestatic liver diseases, Wilson’s disease
Qualifications:
11/2022 Specialist Internal Medicine
06/2022 Dr. med. habil (Habilitation), teaching credentials for experimental medicine
04/2016 M.D. (magna cum laude) with the title „Effects of TNF receptor signalling on the suppressive function of regulatory T cells“ (at the Institute for Immunology, University of Regensburg, Prof. Dr. Daniela M. Männel)
2014 Medical license, University of Regensburg
Awards:
Since 01/2020 Funding by TransBioLine (Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease; Grant Agreement ID: 821283)
Since 05/2020 Funding by Friedrich-Baur Foundation for the research project „In-depth analysis of different subgroups of patients with drug-induced liver injury based on the Munich DILI database and supported by the monocyte-derived hepatocyte-like cell test system” (grant no. 43/20)
2010-2014 Scholarship of the German Academic Foundation
Publications (selection):
• Weber S, Hellmuth JC, Scherer C, Muenchhoff M, Mayerle J, Gerbes AL. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut. 2021 Jan 29. doi:10.1136/gutjnl-2020-323800. Epub ahead of print.
• Weber S, Benesic A, Neumann J, Gerbes AL. Liver injury associated with metamizole exposure: features of an underestimated adverse event. Drug Saf. 2021 Feb 27. doi:10.1007/s40264-021-01049-z. Epub ahead of print.
• Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic druginduced liver injury from autoimmune hepatitis. Liver Int. 2019 Oct;39(10):1906-1917. doi: 10.1111/liv.14195.